Hemostatic parameters in pulmonary tuberculosis patients after intensive phase treatment
Open Access
- 1 January 2021
- journal article
- research article
- Vol. 12 (3), 294-298
- https://doi.org/10.22088/CJIM.12.3.294
Abstract
Background: Tuberculosis (TB) is an infectious disease caused by mycobacterium tuberculosis (Mtb). This infection causes the release of proinflammatory cytokines that affect hemostasis. Pulmonary TB infection causes an increased activation of procoagulant factors, decreased anticoagulant factors and suppresses fibrinolysis which causes hypercoagulable. Our study is conducted to assess the association ...Keywords
This publication has 14 references indexed in Scilit:
- Pulmonary tuberculosis induces a systemic hypercoagulable stateJournal of Infection, 2015
- Alteration of serum inflammatory cytokines in active pulmonary tuberculosis following anti-tuberculosis drug therapyMolecular Immunology, 2014
- A potential role for D-dimer in the diagnosis of tuberculous pleural effusion.2013
- Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Development of Pulmonary TuberculosisPulmonary Medicine, 2012
- Human Lung Immunity againstMycobacterium tuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Mycobacterium Tuberculosis Infection and Inflammation: what is Beneficial for the Host and for the Bacterium?Frontiers in Microbiology, 2011
- The interactions between inflammation and coagulationBritish Journal of Haematology, 2005
- Normal D-dimer levels in patients with latent tuberculosis infectionBlood Coagulation & Fibrinolysis, 2005
- Hemostatic changes in active pulmonary tuberculosis.2002
- Hypercoagulability SyndromesArchives of Internal Medicine, 2001